Aqua Bio Technology ASA (OSL:ABTEC)
Norway · Delayed Price · Currency is NOK 4.290
-0.420 (-8.92%)
At close: Nov 13, 2026
Aqua Bio Technology ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 64 | 73 | 229 | 189 | 151 | 272 | |
Market Cap Growth | -18.89% | -68.03% | 21.02% | 25.39% | -44.64% | 150.79% |
Enterprise Value | 133 | 179 | 307 | 212 | 156 | 270 |
Last Close Price | 4.29 | 22.93 | 101.59 | 165.02 | 351.76 | 636.93 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 0.75 | - | - | - | - |
Forward PE | - | 11.34 | 11.34 | 11.34 | 11.34 | 11.34 |
PS Ratio | 11.33 | 9.70 | 21.02 | 10.08 | 21.03 | 137.71 |
PB Ratio | 1.55 | -149.42 | -2.12 | 2.20 | 80.96 | 14.54 |
P/TBV Ratio | 1.55 | - | - | - | - | 26.78 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 23.51 | 23.76 | 28.24 | 11.30 | 21.74 | 136.51 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.76 | -222.41 | -1.73 | 0.62 | 9.09 | 0.38 |
Net Debt / Equity Ratio | 1.67 | -216.97 | -1.67 | 0.56 | 8.09 | -0.33 |
Net Debt / EBITDA Ratio | -8.00 | -9.10 | -5.24 | -1.75 | -0.77 | 0.37 |
Net Debt / FCF Ratio | -10.88 | -13.02 | -3.15 | -2.47 | -0.97 | 0.30 |
Asset Turnover | 0.04 | 0.05 | 0.05 | 0.12 | 0.14 | 0.08 |
Inventory Turnover | - | - | 0.48 | 0.52 | 0.57 | 0.21 |
Quick Ratio | 0.62 | 0.03 | 0.07 | 0.19 | 0.17 | 1.14 |
Current Ratio | 0.62 | 0.03 | 0.10 | 0.41 | 0.51 | 1.81 |
Return on Equity (ROE) | -115.14% | - | - | -47.98% | -182.19% | -141.43% |
Return on Assets (ROA) | -1.84% | -4.78% | -10.81% | -12.00% | -25.47% | -44.05% |
Return on Invested Capital (ROIC) | -4.30% | - | -61.80% | -38.95% | -141.00% | -219.70% |
Return on Capital Employed (ROCE) | -4.20% | -2549.60% | 200.20% | -24.80% | -48.90% | -79.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -104.19% | 133.71% | -158.98% | -11.13% | -12.44% | -7.03% |
FCF Yield | -9.88% | -11.16% | -25.06% | -10.24% | -10.26% | -7.71% |
Buyback Yield / Dilution | -272.72% | -85.97% | -122.82% | -47.34% | -7.88% | -18.67% |
Total Shareholder Return | -272.72% | -85.97% | -122.82% | -47.34% | -7.88% | -18.67% |